To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
DRI expects to launch Fund III later this year
The Toronto-based drug royalty-focused firm closed its second fund on $701m last year and has been investing at a quick pace.
